By Carlo Martuscelli 
 

The U.K.'s Competition and Markets Authority has opened an investigation into the acquisition of Spark Therapeutics Inc. by Roche Holding AG (RO.EB).

The regulator said it is looking into whether the deal will result in a substantial lessening of competition, and has set Dec. 16 as its deadline to decide whether it will continue the investigation.

Roche said it agreed to buy the Philadelphia biotechnology company in February in a bid to expand its presence in hemophilia treatment.

 

Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com; @carlomartu

 

(END) Dow Jones Newswires

October 22, 2019 02:31 ET (06:31 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Jul 2020 to Aug 2020 Click Here for more Roche (QX) Charts.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Aug 2019 to Aug 2020 Click Here for more Roche (QX) Charts.